Testing new TB screening and diagnostic tests
Part of Infections clinical trials.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an outpatient adult or teen age 12+ (not currently hospitalized)
- Have symptoms like cough lasting 2 or more weeks OR a TB risk factor
- If you have HIV, close contact, or past mining work, you must screen positive using a WHO-recommended symptom/chest X-ray check
- Be able to return for follow-up visits and live within 20 km of the study site
- If you already had TB treatment in the last 12 months, you can’t join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new tools that can check for tuberculosis (TB) more quickly at or near where care happens. It includes people with cough or TB risk factors, and also the health workers who perform TB testing, to see how well the tests work and how easy they are to use.
This study tests new, faster ways to detect tuberculosis (TB) using phlegm, tongue swabs, or urine. It aims to find a simpler and more accurate test than current ones, which could help you get the right treatment sooner.
This study is testing new ways to quickly diagnose TB in children under 15. It aims to find better tests that can be used at clinics, especially for kids who may not have obvious symptoms.
This study tests a new blood test to see if it can help monitor how well TB treatment is working. It may provide a faster and easier way to check progress than current methods.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.